Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Legionnaires disease associated with a whirlpool spa display - Virginia, September-October 1996

Article Abstract:

Whirlpool spas may become contaminated with Legionella, the bacterium that causes Legionnaire's disease. In Oct, 1996, the Virginia Department of Health was notified of several cases of Legionnaire's disease at 2 hospitals. An investigation by the CDC uncovered 23 cases. A detailed analysis of 15 of those cases revealed that 14 of the patients had visited a home improvement center that had a whirlpool spa on display. In two cases, the bacterium isolated from sputum samples matched a Legionella species found in the filter of one of the spas. The patients were probably exposed as they walked by the spa.

Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1997
Causes of, Health clubs, Contamination, Whirlpools

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Legionnaires disease associated with potable water in a hotel-ocean city, Maryland, October 2003-February 2004

Article Abstract:

Eight cases of Legionnaires disease (LD) were identified in October 2003-Feburary 2004 among guests at a hotel in Ocean City, Maryland, implying the potable hot water system of the hotel as the most likely source of infection. A confirmed case of LD was defined as radiographically confirmed pneumonia with laboratory evidence of Legionella infection in a resident or visitor to Ocean City during October 2003-February 2004, whose illness began within 10 days of time spent in Ocean City.

Author: Davenport, M., Goeller, D., Fields, B., Blythe, D., Moore, M., Castel, A. D., Blackburn, M., Hicks, L., Flannery, B.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
Drinking water, Legionellosis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease

Article Abstract:

Two population-based case-control studies were conducted to assess whether the use of gastric acid-suppressive agents is associated with increased risk of Clostridium difficile-associated disease (CDAD) in the community. The findings suggested that prescribed use of gastric acid-suppressive therapy, particularly proton pump inhibitor, is associated with an increased risk of community-acquired Clostridium difficile.

Author: Suissa, Samy, Barkun, Alan N., Dial, Sandra, Delaney, J.A.C.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
Pharmaceutical Preparation Manufacturing, Digestive & Genito-Urinary Preps, Usage, Proton pump inhibitors, Gastrointestinal agents, Clostridium difficile

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Legionnaires' disease, United States, Risk factors
Similar abstracts:
  • Abstracts: Large vessel occlusive disease associated with CREST syndrome and scleroderma. Antinuclear and antiphospholipid autoantibodies in patients with peripheral arterial occlusive disease
  • Abstracts: Imported cholera associated with a newly described toxigenic Vibrio cholerae O139 strain - California, 1993. Challenges for communicable disease surveillance and control in southern Iraq, April-June 2003
  • Abstracts: Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua
  • Abstracts: Antibodies to DNA. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus
  • Abstracts: Prevention of contrast-induced nephropathy with sodium bicarbonate. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.